Author:
Pegu Rupa,Borah Rohan,Pratihar Sanjay
Reference38 articles.
1. Andriole VT (1998) Current and future therapy of invasive fungal infections. Curr Clin Top Infect Dis 18:19–36
2. Andriole VT (1999) Current and future antifungal therapy: new targets for antifungal agents. J Antimicrob Chemother 44:151–162
3. Borelli C, Klövekorn G, Ernst T-M, Bödeker R-H, Korting HC, Neumeister C et al (2007) Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis. Am J Clin Dermatol 8(6):371–378
4. Bossche HV (1997) Mechanisms of antifungal resistance. Rev Iberoam Micol 14:44–49
5. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC et al (2009) In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol 35(6):658–663